Patent Holder

Jitendra Mishra

INVENTION DISCLOSURE/PATENT APPLICATIONS:
1. Bicyclic Heteroaryls as Kinase Inhibitors, Yangbo Feng, Yen Ting Chen, Hampton Sessions, Jitendra K. Mishra, Sarwat Chowdhury, Yan Yin, Philip Lograsso, Jun-Li Luo, Thomas Bannister, Thomas Schroeter PCT Int. Appl. (2011), WO 2011050245 A1 20110428.
2. Compounds for anti-cancer therapy having dual affinity for the essential amino acid transporter Slc7a5/LATI and for the monocarboxylate transporter Mct1 and/or Mct4; Thomas D. Bannister, William R. Roush, John L. Cleveland, Chunying Yang, Jitendra K. Mishra.
3. Anti-cancer therapy provided through the co-administration of biguanides and inhibitors of the monocarboxylate transporters Mct1 (Slc16a1) and/or Mct4 (Slc16a3); Thomas D. Bannister, William R. Roush, John L. Cleveland, Chunying Yang, Jitendra K. Mishra.
4. Compounds for anti-cancer therapy having dual affinity for the glutamine amino acid transporter Asct2 [Slc1a5] and for the monocarboxylate transporter Mct1 (Slc16a1); Thomas D. Bannister, William R. Roush, John L. Cleveland, Chunying Yang, Jitendra K. Mishra.